Cargando…

Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia

INTRODUCTION: PRESENCE was a phase 2 clinical trial assessing the efficacy of mevidalen, a D1 receptor positive allosteric modulator, for symptomatic treatment of Lewy body dementia (LBD). Mevidalen demonstrated improvements in motor and non-motor features of LBD, global functioning, and actigraphy-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Battioui, Chakib, Man, Albert, Pugh, Melissa, Wang, Jian, Dang, Xiangnan, Zhang, Hui, Ardayfio, Paul, Munsie, Leanne, Hake, Ann Marie, Biglan, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Reports – Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315006/ https://www.ncbi.nlm.nih.gov/pubmed/37404864 http://dx.doi.org/10.1159/000529623

Ejemplares similares

Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia
por: Wang, Jian, et al.
Publicado: (2022)

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial
por: Biglan, Kevin, et al.
Publicado: (2021)

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
por: Goldman, Jennifer G., et al.
Publicado: (2020)

Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting
por: Goldman, Jennifer G., et al.
Publicado: (2021)

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease
por: Wilbraham, Darren, et al.
Publicado: (2021)

Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database
por: Chandler, Julie, et al.
Publicado: (2022)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Exploring the prevalence of undetected bradyarrhythmia in dementia with Lewy bodies
por: Heyman, Isak, et al.
Publicado: (2023)

Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
por: Phillips, Joseph R., et al.
Publicado: (2022)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Differentiating Dementia with Lewy Bodies from Alzheimer's Disease Using the Fall Risk Evaluation Questionnaire
por: Tsujimoto, Masashi, et al.
Publicado: (2021)

Characteristics of Parkinson’s Disease in Patients with and without Cognitive Impairment
por: Chandler, Julie M., et al.
Publicado: (2021)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Behavioural and Cognitive Changes in Lewy Body Dementias
por: Kung, Woon-Man, et al.
Publicado: (2018)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

A proteomic signature for dementia with Lewy bodies
por: O'Bryant, Sid E., et al.
Publicado: (2019)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Neurophysiological biomarkers for Lewy body dementias
por: Cromarty, Ruth A., et al.
Publicado: (2016)

Exome sequencing in dementia with Lewy bodies
por: Keogh, M J, et al.
Publicado: (2016)

Clinical prevalence of Lewy body dementia
por: Kane, Joseph P. M., et al.
Publicado: (2018)

Dementia with Lewy bodies: an update and outlook
por: Outeiro, Tiago Fleming, et al.
Publicado: (2019)

Young-Onset Dementia with Lewy Bodies
por: Aiba, Yosuke, et al.
Publicado: (2018)

Pharmacological Management of Dementia with Lewy Bodies
por: Hershey, Linda A., et al.
Publicado: (2019)

Spatial Perseveration in Dementia with Lewy Bodies
por: Assal, Frédéric, et al.
Publicado: (2007)

Clinical diagnosis of Lewy body dementia
por: Surendranathan, Ajenthan, et al.
Publicado: (2020)

Gut microbiota in dementia with Lewy bodies
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022)

Onset matters in dementia with Lewy bodies
por: Müller, Sebastian Johannes, et al.
Publicado: (2023)

Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
por: Jellinger, Kurt A., et al.
Publicado: (2018)

Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia
por: Colloby, Sean J, et al.
Publicado: (2019)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

Improving the clinical detection of Lewy body dementia with the Lewy body composite risk score
por: Galvin, James E.
Publicado: (2015)

Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study
por: Thomas, Alan J., et al.
Publicado: (2018)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Imaging Improves Diagnosis of Dementia with Lewy Bodies
por: Tateno, Masaru, et al.
Publicado: (2009)

Lewy body dementia: the impact on patients and caregivers
por: Zweig, Yael R, et al.
Publicado: (2014)

Neuroimaging, Biomarkers, and Management of Dementia with Lewy Bodies
por: Hanagasi, Hasmet A., et al.
Publicado: (2013)

Visual cortical excitability in dementia with Lewy bodies
por: Taylor, John-Paul, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a43igp1itrhdbdnluapdc9btl5